--- title: "Multi-Chem (SGX:AWZ) Stock Grapples With Margin Squeeze And Thin Dividend Cover" type: "News" locale: "en" url: "https://longbridge.com/en/news/295658374.md" description: "Multi-Chem (SGX:AWZ) faces margin squeeze and thin dividend cover. H1 2026 revenue declined 11.8% to S$300.97m, while net income eased 1.3%. Trailing net profit margin compressed to 3.9% from 4.5%. Despite a 7.78% dividend yield, current earnings provide weak coverage, raising sustainability concerns amid pressure on profitability." datetime: "2026-08-12T11:33:25.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295658374.md) - [en](https://longbridge.com/en/news/295658374.md) - [zh-HK](https://longbridge.com/zh-HK/news/295658374.md) generator: "portal-rs" --- # Multi-Chem (SGX:AWZ) Stock Grapples With Margin Squeeze And Thin Dividend Cover Multi-Chem entered this earnings season with a reputation as a quietly cheap electronics supplier and a stock that had already logged a solid 90 day gain of about 10%. Yet the fresh H1 2026 numbers tell a more complicated story. Trailing net profit margin now sits at 3.9% while earnings over the past year softened against a five year earnings growth record of 5.8% a year. The headline is not growth. It is pressure on profitability and on a dividend yield of 7.78% that is not well covered by current earnings. Love Multi-Chem's 7.78% dividend yield but concerned about pressure on margins and coverage from current earnings? Consider our 435 dividend fortresses for ideas that combine income with sturdier fundamentals. ## H1 2026 Earnings Summary - **Revenue (H1 2026 vs H1 2025):** S$300.972 million vs. S$341.151 million (revenue declined 11.8%) - **Net Income (H1 2026 vs H1 2025):** S$14.213 million vs. S$14.398 million (net income softened 1.3%) - **Basic EPS (H1 2026 vs H1 2025):** S$0.157755 vs. S$0.159809 (EPS eased 1.3%) - **Trailing Net Profit Margin (TTM, last 12 months):** 3.9% vs. 4.5% in the prior year period (margin compressed by 0.6 percentage points) If you prefer clean charts instead of another wall of earnings tables and payout ratios, you can see how Multi-Chem's dividend profile compares with its broader financial picture in an easy visual format through our company report for Multi-Chem. SGX:AWZ Trailing 12-Month Earnings & Revenue History as at Aug 2026 ## Multi-Chem bullish signals look more muted now For investors hoping Multi-Chem would quietly compound, the latest figures are more mixed. Revenue for H1 2026 declined 11.8% while net income eased 1.3%. That pattern suggests some resilience in cost control even as the top line came under pressure. The share price still shows a 90 day gain of about 10%, which indicates investors have not abandoned the story. However, with trailing net margin at 3.9% and earnings softer versus the five year growth record, the bullish view now leans more on stability than on clear operational momentum. ## Bearish concerns on margins and dividends reinforced The cautious narrative around Multi-Chem finds stronger support in these results. Trailing net margin slipped from 4.5% to 3.9% while revenue declined 11.8%. That points to pressure on both volume and profitability. At the same time, the stock carries a 7.78% dividend yield that is not well covered by current earnings, which raises questions on sustainability if conditions stay similar. Recent price gains over 7, 30 and 90 days suggest the market is not pricing in severe stress today, but the earnings profile does little to reduce longer term margin and payout worries. With Multi-Chem facing thinner margins and a dividend that current earnings do not fully cover, it is worth asking whether these are isolated pressure points or signs of deeper fragility in the business model. Review our independent risk analysis for Multi-Chem which shows 2 important warning signs to scan for hidden vulnerabilities, structural weak spots and other risks already scored for you. ## Stay Ahead With Simply Wall St If Multi-Chem's thinner margins and uncovered dividend make you want to watch the story unfold before acting, register for free with Simply Wall St and add it to a Watchlist so you can track price against fair value and wait for a setup that fits your plan. When you do decide to take a position, use the Portfolio Command Center to cut through noise and focus on the most important fundamental and valuation updates on your holdings. For a longer term view, tap into the Community to see how other investors are thinking about risks, rewards and turning points. That way you can spot potential catalysts and pressure points early and stay a step ahead of the market. ## Seeking Alternatives Beyond Multi-Chem Now Some stocks are building quiet breakout momentum while the crowd stays focused elsewhere. Before these fresh ideas stop flying under the radar, review them while it matters and consider them in a timely way. - Scan for steadier compounders with room to run by reviewing our curated list of solid balance sheet and fundamentals stocks (422 results) that highlights businesses where cash flow and balance sheets still look ready for the next move. - Spot potential breakout leaders in robotics and automation by checking the hand picked 39 robotics and automation stocks that surfaces companies already building real traction before the crowd catches on. - Focus on structural power grid upgrades rather than short term stories by using the focused 36 power grid technology and infrastructure stocks that groups infrastructure stocks positioned for ongoing investment flows. *This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.* ### **New:** Manage All Your Stock Portfolios in One Place We've created the **ultimate portfolio companion** for stock investors, **and it's free.** • Connect an unlimited number of Portfolios and see your total in one currency • Be alerted to new Warning Signs or Risks via email or mobile • Track the Fair Value of your stocks Try a Demo Portfolio for Free ### Related Stocks - [AWZ.SG](https://longbridge.com/en/quote/AWZ.SG.md) ## Related News & Research - [Multi-Chem hit by key vendor order suspension, warns of earnings impact](https://longbridge.com/en/news/299907479.md) - [CPIB hauls Multi-Chem CEO, COO in for questioning; stock hits circuit breaker](https://longbridge.com/en/news/299383944.md) - [Oracle Corporation $ORCL Stock Holdings Decreased by Bank of New Hampshire](https://longbridge.com/en/news/301083742.md) - [CoreWeave CEO Dumps $347 Million of Stock](https://longbridge.com/en/news/301171859.md) - [Marvell Now Sees as Much as $90 Billion in Annual Sales by Fiscal 2031. Here's Why It's a Chip Stock to Buy.](https://longbridge.com/en/news/301114413.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**